EAM Investors, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 45 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$288,000
-35.9%
160,628
-32.3%
0.07%
-41.8%
Q4 2018$449,000
-32.1%
237,409
+28.2%
0.12%
+24.5%
Q3 2018$661,000185,2270.10%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ESSEX INVESTMENT MANAGEMENT CO LLC 1,136,282$2,148,0000.17%
EAM Investors, LLC 237,409$449,0000.12%
BARD ASSOCIATES INC 89,559$169,0000.10%
HighTower Advisors, LLC 5,260,088$9,942,0000.08%
Kore Private Wealth LLC 75,866$143,0000.04%
Regal Investment Advisors LLC 69,950$132,0000.03%
Paragon Capital Management Ltd 24,750$47,0000.02%
Alpine Global Management, LLC 45,994$87,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 67,204$127,0000.02%
BlueCrest Capital Management Ltd 113,480$214,0000.01%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders